Bortezomib in Patients With Chronic Graft Versus Host Disease

NCT01672229 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Graft Versus Host Disease

Interventions

DRUG: Bortezomib

Sponsor

Mehrdad Abedi, MD

Collaborators

[object Object]